Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Banminth
2. Tartrate, Pyrantel
1. 33401-94-4
2. Pyrantel Tartrate Salt
3. Banminth
4. Pyrantel Tartrate [usan]
5. Pyrantel (tartrate)
6. Pyrantel (+)-tartrate Salt
7. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (e)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1)
8. Sc82vf0480
9. (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine Tartrate (1:1)
10. Pyrequan Tartrate
11. Cp-10,423-18
12. Dsstox_cid_28784
13. Dsstox_rid_83053
14. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)-, (e)-, Tartrate (1:1)
15. Dsstox_gsid_48858
16. (2r,3r)-2,3-dihydroxybutanedioic Acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine
17. Pyrantel Bitartrate
18. Pyrantel Hydrogen Tartrate
19. Banminth 48
20. Einecs 251-501-8
21. Unii-sc82vf0480
22. Cp 10423-18
23. (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine Tartrate (1:1)
24. Ncgc00017103-02
25. Banminth (tn)
26. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]-, (e)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1)
27. Cas-33401-94-4
28. Pyranteltartrate
29. Prestwick3_000212
30. Pyrantel Tartrate (usp)
31. Bspbio_000223
32. Schembl536109
33. Pyrantel Tartrate [mi]
34. Bpbio1_000247
35. Chembl2105309
36. Dtxsid4048858
37. Hms2095l05
38. Hms3712l05
39. Pyrantel Tartrate [usp-rs]
40. Tox21_113347
41. Akos016014952
42. Pyrantel Tartrate [green Book]
43. Tox21_113347_1
44. Ccg-220212
45. Cs-3870
46. Ncgc00174007-04
47. Pyrantel Tartrate [usp Monograph]
48. Hy-12641
49. 2(1h)-pyrimidinone, 4,6-diamino-5-nitroso-
50. D05657
51. A875297
52. Sr-01000872648
53. Sr-01000872648-1
54. Q27289138
55. Pyrantel Tartrate, United States Pharmacopeia (usp) Reference Standard
56. Trans-1-methyl-1,4,5,6-tetrahydro-2-(2-(thienyl)vinyl)pyrimidine Tartrate
57. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine (2r,3r)-2,3-dihydroxysuccinate
Molecular Weight | 356.4 g/mol |
---|---|
Molecular Formula | C15H20N2O6S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 356.10420754 g/mol |
Monoisotopic Mass | 356.10420754 g/mol |
Topological Polar Surface Area | 159 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 382 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anthelmintics
Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Pyrantel Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pyrantel Tartrate manufacturer or Pyrantel Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyrantel Tartrate manufacturer or Pyrantel Tartrate supplier.
PharmaCompass also assists you with knowing the Pyrantel Tartrate API Price utilized in the formulation of products. Pyrantel Tartrate API Price is not always fixed or binding as the Pyrantel Tartrate Price is obtained through a variety of data sources. The Pyrantel Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Banminth manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Banminth, including repackagers and relabelers. The FDA regulates Banminth manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Banminth API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Banminth manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Banminth supplier is an individual or a company that provides Banminth active pharmaceutical ingredient (API) or Banminth finished formulations upon request. The Banminth suppliers may include Banminth API manufacturers, exporters, distributors and traders.
click here to find a list of Banminth suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Banminth DMF (Drug Master File) is a document detailing the whole manufacturing process of Banminth active pharmaceutical ingredient (API) in detail. Different forms of Banminth DMFs exist exist since differing nations have different regulations, such as Banminth USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Banminth DMF submitted to regulatory agencies in the US is known as a USDMF. Banminth USDMF includes data on Banminth's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Banminth USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Banminth suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Banminth as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Banminth API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Banminth as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Banminth and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Banminth NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Banminth suppliers with NDC on PharmaCompass.
Banminth Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Banminth GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Banminth GMP manufacturer or Banminth GMP API supplier for your needs.
A Banminth CoA (Certificate of Analysis) is a formal document that attests to Banminth's compliance with Banminth specifications and serves as a tool for batch-level quality control.
Banminth CoA mostly includes findings from lab analyses of a specific batch. For each Banminth CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Banminth may be tested according to a variety of international standards, such as European Pharmacopoeia (Banminth EP), Banminth JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Banminth USP).